#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Kawasaki's disease Necrotising enterocolitis neonatal Idiopathic inflammatory myopathy Still's disease Prostate cancer Chronic myeloid leukaemia (in remission) Myelodysplastic syndrome with excess blasts Microscopic polyangiitis Nodal marginal zone B-cell lymphoma Prader-Willi syndrome Turner's syndrome Multifocal motor neuropathy Pulmonary tuberculosis Progressive supranuclear palsy Paroxysmal nocturnal haemoglobinuria More trials…

    Learn about Rare Diseases

    Mantle cell lymphoma stage IV – Diagnostics Shprintzen-Goldberg syndrome – Basic Information Pleural mesothelioma malignant Glomerulonephritis membranoproliferative – Diagnostics Kearns-Sayre syndrome – Life with Disease Osteosarcoma Alternating hemiplegia of childhood – Diagnostics Rosai-Dorfman syndrome – Life with Disease Primary biliary cholangitis Leiomyosarcoma recurrent More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Kbp-336 Cart 19/22 T Cells Blu-451 Epacadostat Hydrochlorothiazide Protein C Stiripentol Pasireotide Diaspartate Glpg3667 Fumarate Perflutren [89Zr]Bms-986279 Pembrolizumab Rezafungin Acetate Lovo-A Isosorbide Dinitrate Dalteparin Sodium Anifrolumab Pentosan Polysulfate Sodium Gsk3915393 Piperacillin Sodium More therapies…

    Learn about Your Condition

    Head and neck cancer stage III Transplant rejection Placenta praevia Hyperthyroidism Limb reduction defect Albright's disease Endometrial cancer stage II Tuberculosis Chondropathy Ejection fraction normal Corticobasal degeneration Migraine Hepatic neoplasm Adenomatous polyposis coli Hypogonadism male More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on EXL01 to Prevent Recurrence of C. difficile Infection in High-Risk Patients

    Recruiting

    1 1 1
    Investigated Diseases:
    • Clostridium difficile infection
    Investigated Drugs:
    • Exl01
    • Vancomycin
    France

  • Study on the Use of SYN2, Adenosine, and Regadenoson for Diagnosing Coronary Artery Disease in Patients with Suspected Heart Conditions

    Recruiting

    3 1 1 1 1
    Investigated Drugs:
    • Regadenoson
    • Syn2
    • Adenosine
    Finland Germany Italy The Netherlands Poland

  • Study on Letermovir and Valganciclovir for Treating CMV Infections in Kidney Transplant Patients

    Recruiting

    3 1 1
    Investigated Diseases:
    • Cytomegalovirus infection
    Investigated Drugs:
    • Valganciclovir
    • Letermovir
    France

  • Study on the Safety of Long-Term Use of Deucrictibant for Treating Hereditary Angioedema Attacks in Patients with C1-Inhibitor Deficiency

    Recruiting

    4 1 1
    Investigated Diseases:
    • Hereditary angioedema with C1 esterase inhibitor deficiency
    Investigated Drugs:
    • (S)-N-(1-Deutero-1-(3-Chloro-5-Fluoro-2-((2-Methyl-4-(1-Methyl-1H-1,2,4-Triazol-5-Yl)Quinolin-8-Yloxy)Methyl)Phenyl)Ethyl)-2-(Difluoromethoxy)Acetamide
    • Icatibant
    • Deucrictibant
    Austria Bulgaria Czechia France Germany Hungary +8

  • Study on Ureter Imaging with Nizaracianine Triflutate for Patients 18+ Undergoing Abdominopelvic Surgery

    Recruiting

    4 1 1
    Investigated Drugs:
    • Nizaracianine Triflutate
    • Glucose Monohydrate
    The Netherlands

  • Study on PTG-CARCIK-CD19 for Adults and Children with Relapsed or Refractory B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

    Recruiting

    1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia refractory
    Investigated Drugs:
    • Ptg-Carcik-Cd19
    Italy
Previous Page
1 … 551 552 553 554 555 … 1,654
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!